We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Selexis, ImmuNext Announces Cell Line License Agreement

News   Oct 27, 2016

 
Selexis, ImmuNext Announces Cell Line License Agreement
 
 
 

RELATED ARTICLES

Retina Restoration Could Return Vision to Our Canine Friends

News

A stem cell-based approach is being developed to treat blindness in dogs.

READ MORE

150-year-old Drug Could Improve Cancer Radiation Therapy

News

A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study.

READ MORE

New Findings Cast Light on Lymphatic system, Key Player in Human Health

News

Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE